Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pedmark in Men Receiving Cisplatin for Metastatic Germ Cell Tumor
NCT07218913Phase 1Recruiting
- Sponsor
- City of Hope
- Start
- Feb 2026
- Primary completion
- Jan 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of sodium thiosulfate in ototoxicity (2 arms), sponsored by City of Hope. Primary endpoint: Incidence of clinically meaningful ototoxicity at 6 months. Started Feb 2026; status: recruiting.
02
Drugs
sodium thiosulfate
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT07218913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07218913.